Noncatalytic regulation of 18SrRNA methyltransferase DIMT1 in acute myeloid leukemia

Abstract
Several rRNA-modifying enzymes install rRNA modifications while participating in ribosome assembly. Here, we show that 18S rRNA methyltransferase DIMT1 is essential for acute myeloid leukemia (AML) proliferation through a noncatalytic function. We reveal that targeting a positively charged cleft of DIMT1, remote from the catalytic site, weakens the binding of DIMT1 to rRNA and mislocalizes DIMT1 to the nucleoplasm, in contrast to the primarily nucleolar localization of wild-type DIMT1. Mechanistically, rRNA binding is required for DIMT1 to undergo liquid–liquid phase separation, which explains the distinct nucleoplasm localization of the rRNA binding-deficient DIMT1. Re-expression of wild-type or a catalytically inactive mutant E85A, but not the rRNA binding-deficient DIMT1, supports AML cell proliferation. This study provides a new strategy to target DIMT1-regulated AML proliferation via targeting this essential noncatalytic region.
Funding Information
  • National Institutes of Health (R35 GM133721, R01 HL160726, RSG-22-064-01-RMC)
  • American Cancer Research Scholar
  • Damon Runyon (Innovator Award, R35 GM118090, R01 CA258904, T32GM07133398)
  • Heinrich Kronstein Foundation